Results 131 to 140 of about 14,498 (196)

Mitogen-Activated Protein Kinases: Therapeutic Signaling Catalysts in Viral Immune Evasion. [PDF]

Pathogens
Khan MA, Khan MH, Allemailem KS.
europepmc   +1 more source

Natural killer T cells in intracerebral hemorrhage: phase-dependent immune responses and therapeutic implications. [PDF]

Front Immunol
Zhao X, Wang L, Ren S, Yang Z, Wu G.
europepmc   +1 more source

Multifaceted mechanisms of unconventional T cells in ischemia-reperfusion injury. [PDF]

Front Immunol
Li J, Lin P, Yuan M, Wang Y, Liu H, Jia R, Fan J, Liang L, Han P, Guo Q, He Y.   +10 more
europepmc   +1 more source

Enhancing iNKT cell immunotherapy through the integration of optimized CAR endodomains and iNKT engagers. [PDF]

Nat Commun
Ponnusamy K, Karaxhuku K, Jiang Y, Randzavola L, Ren H, Leontari I, Lye B, Zaidi M, Bartlett EJ, Tate EW, Pardalis V, Leonardos D, Nadafi R, Sarkar I, Reijmers RM, Bua M, Atta M, Katsarou A, Roberts IA, Chaidos A, Karadimitris A.   +20 more
europepmc   +1 more source

Machine learning-based integration develops a novel lysosome-related prognostic signature associated with prognosis and immune infiltration landscape in acute myeloid leukemia. [PDF]

Discov Oncol
Lu L, Jiang X, Lu J, Lv J.
europepmc   +1 more source

Natural Killer T Cell Function in Lymphoma Patients. [PDF]

Biomolecules
Derakhshandeh R, Lee MS, Zhu Y, Asiedu EB, Reader J, Younis RH, Kimball AS, Glynn N, Kallen M, Webb TJ.   +9 more
europepmc   +1 more source

Highly Potent Th1-Type NKT Cell Agonists as Immunotherapeutic Agents via Conformational Restriction Design. [PDF]

JACS Au
Wen Y, Wu YH, Sun QN, Wang EY, Luo MQ, Fu ZR, Zhou Z, Mei DX, Guo J.   +8 more
europepmc   +1 more source

Invariant Natural Killer T Cells in Cancer Immunotherapy: Lipid-Based Modulation, Nanotechnology, and Translational Advances. [PDF]

Int J Mol Sci
Aloliqi AA, Alnuqaydan AM, Alshebremi M, Khan A, Khan MA.   +4 more
europepmc   +1 more source

The RNA- and DNA-Binding Protein Y-Box Binding Protein 1 (YB-1) Regulates iNKT Cell Development. [PDF]

Eur J Immunol
Schulze S, Knop L, Jantz-Naeem N, Dovhan V, Fricke S, Kahlfuß S, Schüler T, Bommhardt U.   +7 more
europepmc   +1 more source

Natural Killer T cells promote cholestatic liver disease independent of antigen presentation by cholangiocytes. [PDF]

Hepatol Commun
Valestrand L, Nordhus KS, Claudel T, Øgaard J, Frank A, Amundsen-Isaksen E, Fuchs C, Berntsen NL, Chung BK, Jiang X, Trauner M, Melum E.   +11 more
europepmc   +1 more source